Jul 29, 2022 / 02:00PM GMT
Operator
Ladies and gentlemen, good day, and welcome to the Torrent Pharmaceuticals Limited Q1 FY '23 Earnings Conference Call. We have with us today Mr. Aman Mehta, Executive Director and Chief Marketing Officer, India Business; Mr. Sanjay Gupta, Executive Director, International Business; Mr. Sudhir Menon, Executive Director, Finance and Chief Financial Officer. (Operator Instructions)
I now hand the conference over to Mr. Sudhir Menon. Thank you and over to you, sir.
Sudhir Menon - Torrent Pharmaceuticals Limited - Executive Director of Finance & CFO
Good evening and welcome everyone to Quarter 1 FY '23 earnings call. Quarter 1 continued to witness strong growth momentum in the branded generic market led by robust India performance. The branded generic markets constituted 70% of our total revenue. And on an overall basis grew by 15% on a Y-o-Y basis, aided by market share gain, performance of top brands and new launches. Sequentially, there is an improvement in EBITDA margin mainly led by the cost initiatives which we had guided earlier in the previous
Q1 2023 Torrent Pharmaceuticals Ltd Earnings Call Transcript
Mar 19, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers